Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices

International Journal of Cardiology

Volumn 137, Issue 3, 2009, Pages 314-316

  Shafi, Nabil A ^a,c   McKay, Raymond G ^a,c   Kiernan, Francis J ^a,c   Silverman, Isaac E ^b   Ahlquist, Martha ^b   Silverman, David I ^a,c  

^a Henry Low Heart Center   (United States)

^b HARTFORD HOSPITAL   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Cryptogenic stroke; Patent foramen ovale; Percutaneous closure device; Residual shunting

Indexed keywords

ADULT; ANEURYSM; ARTICLE; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GEOMETRY; HEART RIGHT LEFT SHUNT; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENT DISEASE; STROKE; TERTIARY HEALTH CARE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY;

CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY; EMBOLISM, PARADOXICAL; FEMALE; FORAMEN OVALE, PATENT; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 70749107002     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.06.045     Document Type: Article

References (12)

1. Ruiz C.E., Alboliras E.T., and Pophal S.G. The puncture technique: a new method for transcatheter closure of patent foramen ovale. Catheter Cardiovasc Interv 53 (2001) 369-372
2. Donnan G.A., and David S.M. Patent foramen ovale and stroke: closure by further randomized trial is required!. Stroke 35 (2004) 806
3. Windecker S., and Meier M. Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else!. Circulation 118 (2008) 1989-1997
4. Messé S.R., and Kasner S.E. Patent foramen ovale in cryptogenic stroke: not to close. Circulation 118 (2008) 1999-2004
5. Schneider B., Zienkiewicz T., Jansen V., Hofmann T., Noltenuis H., and Meinertz T. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol 77 (1996) 1202-1209
6. Meschia J.F., Lojacono M.A., Miller M.J., Brott T.G., Atkinson E.J., and O'Brien P.C. Reliability of the questionnaire for verifying stroke-free status. Cerebrovasc Dis 17 (2004) 218-223
7. Hong T.E., Thaler D., Brorson J., et al. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the Amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial. Catheter Cardiovasc Interv 60 (2003) 524-528
8. Zajarias A., Thanigaraj S., Lasala J., and Perez J. Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale. J Invasive Cardiol 18 (2006) 533-537
9. Schwerzmann M., Windecker S., Wahl A., et al. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 90 2 (2004 Feb) 186-190
10. Schwerzmann M., Windecker S., Wahl A., et al. Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv 63 (2004) 490-495
11. Mas J.L., and Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J 130 (1995) 1083-1088
12. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150